Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Opt Soc Am A Opt Image Sci Vis ; 28(4): 590-5, 2011 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-21478954

RESUMEN

We put forward a plan of improving the oblique-incidence optical interferometric system applied in the measurement of tooth flanks of an involute spur gear in order to expand its capability to measure an involute helical gear. On the basis of the features of an involute helical tooth flank, we discuss how to realize the parallelism between the optical axis of the object arm of the optical system and the straight lines constructing the involute helical tooth flank. This parallelism helps the optical system produce an interference fringe pattern as clear as the one of an involute spur gear [Appl. Opt.49, 6409 (2010).]. A numerical simulation is then performed to examine the correctness of the improvement. During simulating, we unify the equation of difference tooth flanks by means of importing two parameters in relation to the left or right side of a tooth flank and the helical direction of teeth, respectively. Finally, the actual experiment is fulfilled through the real optical system built on an optical table. The simulation and experiment results verify the correctness and feasibility of the proposed improvement.

2.
Appl Opt ; 49(33): 6409-15, 2010 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-21102665

RESUMEN

We present a ray-tracing-based method for simulation of interference fringe patterns (IFPs) for measuring gear tooth flanks with a two-path interferometer. This simulation method involves two steps. In the first step, the profile of an IFP is achieved by means of ray tracing within the object path of the interferometer. In the second step, the profile of an IFP is filled with interference fringes, according to a set of functions from an optical path length to a fringe gray level. To examine the correctness of this simulation method, simulations are performed for two spur involute gears, and the simulated IFPs are verified by experiments using the actual two-path interferometer built on an optical platform.

3.
Dis Markers ; 2019: 3862024, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31636735

RESUMEN

BACKGROUND AND AIM: Serum Golgi protein 73 (GP73) is a promising alternative biomarker of chronic liver diseases, but most data are from patients with HBV infection rather than HCV. MATERIALS AND METHODS: Two independent cohorts of chronic hepatitis C (CHC) patients from the 5th Medical Centre of the Chinese PLA General Hospital (n = 174) and Beijing Youan Hospital (n = 120) with different histories of HCV infection were enrolled. The correlations between serum GP73 and other biochemical indices, as well as its correlations with different stages of liver disease progression, were investigated. The receiver operating characteristic (ROC) curve was employed to evaluate the diagnostic potential of serum GP73 for liver necroinflammation and fibrosis, and comparisons of the diagnostic efficiency with traditional indices of hepatic liver injuries were further investigated. RESULTS: Levels of serum GP73 were found significantly elevated in patients with moderate to severe inflammatory grade (G ≥ 2) and/or with advanced fibrotic stages (F ≥ 3) in both cohorts (P < 0.05, respectively), as compared to those with a normal or mild liver lesion. Further ROC analysis demonstrated that serum GP73 was comparable to serum ALT and AST in diagnosing the liver necroinflammation grade at G ≥ 2, but its diagnostic values for advanced fibrosis (F ≥ 3) and cirrhosis (F = 4) were limited when compared to APRI and FIB-4, and FIB-4 exhibited the best performance. Notably, an obvious elevation of serum GP73 was observed after patients received PEG-IFN and ribavirin treatment. CONCLUSIONS: Serum GP73 is an important biomarker in evaluating and monitoring the disease progression including liver necroinflammation and fibrosis in patients with chronic HCV infection, but the value is limited for diagnosing advanced fibrosis and cirrhosis in comparison with APRI and FIB-4.


Asunto(s)
Enfermedad Hepática en Estado Terminal/sangre , Hepatitis C Crónica/sangre , Cirrosis Hepática/sangre , Proteínas de la Membrana/sangre , Adulto , Biomarcadores/sangre , Progresión de la Enfermedad , Enfermedad Hepática en Estado Terminal/diagnóstico , Enfermedad Hepática en Estado Terminal/tratamiento farmacológico , Femenino , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/tratamiento farmacológico , Humanos , Inflamación , Interferón-alfa/uso terapéutico , Cirrosis Hepática/diagnóstico , Masculino , Persona de Mediana Edad , Polietilenglicoles , Curva ROC , Ribavirina/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA